US Congress House Bill 4374 (Prior Session Legislation)

---

Completed Legislative Action
Spectrum: Partisan Bill (Republican 1-0)
Status: Passed on December 12 2017 - 100% progression
Action: 2017-12-12 - Became Public Law No: 115-92. (TXT | PDF)
Text: Latest bill text (Enrolled) [PDF]

To amend the Federal Food, Drug, and Cosmetic Act to authorize additional emergency uses for medical products to reduce deaths and severity of injuries caused by agents of war, and for other purposes. (Sec. 1) This bill amends the Federal Food, Drug, and Cosmetic Act to allow the Food and Drug Administration (FDA) to authorize the emergency use of an otherwise unapproved medical product if the Department of Defense (DOD) determines that there is a military emergency involving an agent that may cause imminently life-threatening and specific risk to U.S. forces. If a military emergency is determined to exist, the bill allows DOD to request that the FDA expedite certain procedures for approving medical products that would be reasonably likely to diagnose, prevent, treat, or mitigate such risk. The FDA must take specified actions to facilitate such a request by DOD. The bill repeals provisions of the National Defense Authorization Act for Fiscal Year 2018 that allow DOD, rather than the FDA, to authorize the emergency use of an unapproved product under similar circumstances. Unless DOD determines such meetings to be unnecessary, the FDA shall meet with DOD: (1) semi-annually to conduct a full review of relevant medical products in the DOD portfolio; and (2) quarterly to discuss the development status of regenerative medicine advanced therapy, blood, and vaccine medical products and projects that DOD prioritizes.

To amend the Federal Food, Drug, and Cosmetic Act to authorize additional emergency uses for medical products to reduce deaths and severity of injuries caused by agents of war, and for other purposes.

Rep. Greg Walden [R-OR]

Date	Chamber	Action
2017-12-12	Senate	Became Public Law No: 115-92. (TXT | PDF)
2017-12-12	Senate	Signed by President.
2017-11-30	Senate	Presented to President.
2017-11-16	Senate	Message on Senate action sent to the House.
2017-11-16	Senate	Passed Senate without amendment by Unanimous Consent. (consideration: CR S7270)
2017-11-15	Senate	Received in the Senate, read twice.
2017-11-15	House	Motion to reconsider laid on the table Agreed to without objection.
2017-11-15	House	On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H9297-9298)
2017-11-15	House	DEBATE - The House proceeded with forty minutes of debate on H.R. 4374.
2017-11-15	House	Considered under suspension of the rules. (consideration: CR H9297-9300)
2017-11-15	House	Mr. Walden moved to suspend the rules and pass the bill.
2017-11-14	House	Referred to the Subcommittee on Military Personnel.
2017-11-13	House	Referred to the Committee on Energy and Commerce, and in addition to the Committee on Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2017-11-13	House	Referred to the Committee on Energy and Commerce, and in addition to the Committee on Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2017-11-13	House	Introduced in House

Type	Source
Summary	https://www.congress.gov/bill/115th-congress/house-bill/4374/all-info
Text	https://www.congress.gov/115/bills/hr4374/BILLS-115hr4374ih.pdf
Text	https://www.congress.gov/115/bills/hr4374/BILLS-115hr4374eh.pdf
Text	https://www.congress.gov/115/bills/hr4374/BILLS-115hr4374enr.pdf